World · India Bureau
Canadian family of Indian origin fundraises for US gene therapy
An Indian-origin family in Canada is raising $5.5 million to access experimental gene therapy in the United States for their toddler diagnosed with a rare genetic disorder. The treatment offers potential hope for a condition with limited conventional therapeutic options.
LSN India ·

A family of Indian descent residing in Canada has launched a fundraising campaign to secure $5.5 million for their young child's access to advanced gene therapy treatment available in the United States. The toddler has been diagnosed with a rare genetic disorder that currently has limited treatment pathways through conventional medical approaches.
Gene therapy represents an emerging treatment frontier for inherited genetic conditions, offering the possibility of addressing disease at its molecular source. The experimental treatment the family seeks is not yet widely available or approved in Canadian healthcare systems, necessitating the significant financial commitment required for access in the United States.
The family's initiative highlights the growing trend of patients and caregivers seeking cutting-edge treatments beyond their home countries' borders. Such cases often underscore disparities in access to advanced medical technologies between nations and raise important questions about healthcare equity and innovation distribution.
Rare genetic disorders often place substantial financial and emotional burdens on affected families. Gene therapy represents one of the most promising developments in medical science for conditions previously considered untreatable, though access remains limited by cost and regulatory approval timelines across different jurisdictions.